Alimera Sciences (ALIM) Misses Q4 EPS by 7c

Alimera Sciences (NASDAQ: ALIM) reported Q4 EPS of ($0.10), $0.07 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $9.14 million versus the consensus estimate of $12.17 million.

For earnings history and earnings-related data on Alimera Sciences (ALIM) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Nordson Corp. (NDSN) Tops Q3 EPS by 16c; Offers Guidance
• Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance